EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access

Starting hepatitis C treatment during acute care hospitalizations: A qualitative study of barriers and facilitators

Erin Bredenberg iD, Catherine Callister, Ashley Dafoe, Brooke Dorsey Holliman, Sarah E Rowan, Susan L Calcaterra iD

Journal of Hospital Medicine · 2025-12 · 20 (12) · 1323-1331

DOI: 10.1002/jhm.70097 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift Journal of Hospital Medicine, online erschienen am 11.06.2025. Verfasst von Erin Bredenberg und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hospital Medicine, University of Colorado, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Hepatitis C, Hospitalization, Antiviral Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatitis C (HCV) is a chronic, prevalent disease that disproportionately affects people who use drugs in the United States. One strategy to decrease HCV prevalence is the initiation of treatment during hospitalization. Factors affecting the success of this approach are not well‐characterized in the literature. Subspecialty providers in fields that treat substantial numbers of patients with HCV are well‐positioned to describe factors affecting treatment provision.

Objectives

To understand barriers and facilitators of inpatient hepatitis C treatment from the perspectives of subspecialty physicians in the United States.

Methods

In this qualitative research study, we interviewed 20 infectious diseases, hepatology, and addiction medicine physicians at 12 medical institutions across the United States. We analyzed interviews using a rapid matrix technique.

Results

Four major themes emerged: (1) hospitalization can be a gateway to care for patients who otherwise might not receive HCV treatment; (2) patients are vulnerable to being lost to follow‐up in the transition from inpatient to outpatient care; (3) the inpatient payment model is a barrier to widespread implementation of programs to treat HCV during hospitalization; and (4) treatment protocols and project “champions” can support inpatient HCV treatment initiatives.

Conclusions

Physicians view hospitalization as an opportunity for patients to start HCV treatment. However, they have concerns about patients becoming lost to follow‐up after hospital discharge. Interviewees perceived that these concerns could be mitigated by implementing standardized protocols for HCV treatment with clear process ownership, as well as by dedicated funding for care navigators and systems champions. Lastly, physicians report that insurance coverage and reimbursement present major barriers to inpatient HCV treatment initiation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis CHospitalizationAntiviral AgentsHumansQualitative ResearchUnited StatesMaleFemale

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Division of Hospital Medicine, University of Colorado, Aurora, Colorado, USA.
  • Adult and Child Center for Health Outcomes Research and Delivery Science, Aurora, Colorado, USA.
  • Department of Family Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Denver Health and Hospital Authority, Denver, Colorado, USA.
  • Division of Infectious Diseases, University of Colorado, Aurora, Colorado, USA.
  • Division of General Internal Medicine, University of Colorado, Aurora, Colorado, USA.

ORCID-Profile: Erin Bredenberg, Susan L Calcaterra

Förderung

  • NIDA NIH HHS

Zitieren

APA

Bredenberg, E., Callister, C., Dafoe, A., Holliman, B. D., Rowan, S. E., & Calcaterra, S. L. (2025). Starting hepatitis C treatment during acute care hospitalizations: A qualitative study of barriers and facilitators. Journal of Hospital Medicine, 20(12), 1323-1331. https://doi.org/10.1002/jhm.70097

Vancouver

Bredenberg E, Callister C, Dafoe A, Holliman BD, Rowan SE, Calcaterra SL. Starting hepatitis C treatment during acute care hospitalizations: A qualitative study of barriers and facilitators. Journal of Hospital Medicine. 2025;20(12):1323-1331. doi:10.1002/jhm.70097

BibTeX
@article{Bredenberg2025,
  author = {Bredenberg, Erin and Callister, Catherine and Dafoe, Ashley and Holliman, Brooke Dorsey and Rowan, Sarah E and Calcaterra, Susan L},
  title = {Starting hepatitis C treatment during acute care hospitalizations: A qualitative study of barriers and facilitators},
  journal = {Journal of Hospital Medicine},
  year = {2025},
  volume = {20},
  number = {12},
  pages = {1323--1331},
  doi = {10.1002/jhm.70097}
}
Kostenlos starten →